Preclinical Evaluation of the First in Class BMI1 Inhibitor PTC-028 Confirms Potent Efficacy to Target BMI1-Addiction in Multiple Myeloma
| Autor: | Bolomsky, Arnold *, Heusschen, Roy *, Stangelberger, Kathrin *, Joséphine, Muller *, Weetall, Marla *, Branstrom, Art *, Zojer, Niklas *, Caers, Jo *, Ludwig, Heinz |
|---|---|
| Zdroj: | In Blood 8 December 2017 130 Supplement 1:1804-1804 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|